Onconova Therapeutics, Inc. 4
4 · Onconova Therapeutics, Inc. · Filed Dec 22, 2014
Insider Transaction Report
Form 4
MCKEARN THOMAS J
President, R&D
Transactions
- Award
Stock Option (right to purchase)
2014-12-18+75,000→ 75,000 totalExercise: $3.98Exp: 2024-12-18→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]These options vest over 4 years in 48 equal monthly installments.